Acute Graft Versus Host Disease Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 4
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals36 enrolled17 locationsNCT06462469
Recruiting
Phase 3
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD
Acute Graft Versus Host Disease
Peking University People's Hospital218 enrolled2 locationsNCT05921305